Musk's $97B OpenAI Bid Is a Delaware Chancery Court Chess Move: A Primer on the Revlon Rule, Nonprofit Fiduciary Duty, and Why an Unsolicited Term Sheet Can Wreck a 409A Valuation

On 8 June 2026, in the closing minutes of a market week that had already absorbed a major Pentagon procurement shake-up and a meme-coin graduation-rate autopsy, TBPN host Jordy opened the show with a single figure: Elon Musk had submitted an unsolicited bid of approximately $97.1–97.4 billion to acquire OpenAI's nonprofit parent. The number landed. Sam Altman, asked about the bid the next day at the Paris AI Summit with Vice President JD Vance and President Emmanuel Macron at his side, did not feign surprise. "OpenAI is not for sale," he said. "The OpenAI mission is not for sale. Elon tries all sorts of things for a long time… I wish he would just compete by building a better product but I think there's been a lot of tactics, you know, many many lawsuits, all sorts of other crazy stuff." That, on its own, is a routine Silicon Valley catfight. The interesting question is not whether Musk wants to own ChatGPT; the interesting question is what kind of lawsuit a $97.4 billion piece of paper creates the moment it lands on the board's desk.

This is a primer on why the bid is, structurally, a Delaware Chancery Court chess move — a piece of paper designed not to close, but to detonate. To understand the move, three pieces of corporate-law scaffolding have to be visible: the Revlon rule and the duty to maximize value in a sale situation; the special fiduciary obligations of a nonprofit board; and the way an unsolicited term sheet can blow up a 409A valuation, the third-party appraisal that prices the equity in a for-profit conversion. The Musk bid touches all three at once.

The Bid, the Bidders, and the Context

The Musk bid is the latest escalation in a long-running personal and legal feud between Musk and the company he co-founded in 2015. Musk's xAI is one of the few organisations globally building frontier-scale models in direct competition with OpenAI, and the dispute has already produced several rounds of litigation over the original nonprofit's governance. The roughly $97.1–97.4 billion figure — discussed at the top of TBPN on 8 June 2026 — places the bid well above the roughly $40 billion valuation reportedly assigned to OpenAI's nonprofit in its prior go-private discussions, and several multiples above the implied value of the for-profit arm's most recent tender offers. That pricing gap is not an accident. It is the move.

The legal-theory read, articulated on X by @sbattorney and read aloud on the broadcast: "The previous go-private price was $40 billion. He's playing chess… Musk's bid isn't about just buying OpenAI, it's about forcing a decision. If OpenAI's board considers transitioning fully into a for-profit company, Musk's bid puts them in a position where they might have to apply Revlon rules." In other words, a bid above the company's last clean valuation does not need to be accepted. It needs to be received — and once received, it triggers a cascade of fiduciary obligations that the board cannot easily wave away.

The Revlon Rule, in Plain English

Revlon is shorthand for Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc. (1986), the Delaware Supreme Court decision that held that once a board determines the company is "for sale" — either by agreeing to a deal, by abandoning its defensive posture, or by conducting an auction — the directors' fiduciary duty shifts from preserving the corporation to maximising value for shareholders. The board must run a process designed to get the best price reasonably available, and it must justify any decision to accept a lower offer.

Revlon does not apply to every corporate decision. It applies when the company is on the block. The doctrine's sharpest edge is procedural: a board that has not run a Revlon-compliant process faces a fairness hearing in Delaware Chancery Court, where the burden of proof shifts to the directors to show they got the best deal, and the transaction can be unwound or subject to damages. A board that has run a Revlon-compliant process, by contrast, enjoys the protection of the business-judgment rule, which presumes directors acted on an informed basis, in good faith, and in the honest belief that their decision served the company's best interests.

For a typical public company, the Revlon question is a fact-intensive inquiry: was there a single bidder, an auction, a stalking-horse? Did the board engage with the highest offer? For OpenAI, the question is structurally stranger: the entity Musk is bidding for is a nonprofit, and nonprofit directors do not owe duties to shareholders. They owe duties to the mission — in OpenAI's case, the safe development of artificial general intelligence for the benefit of humanity. That is where the legal grey area begins.

Nonprofit Fiduciary Duty vs. For-Profit Conversion

A nonprofit board is not free to accept the highest bid, because there are no shareholders to enrich. A nonprofit board is, however, free to convert — to restructure the entity into a for-profit, transfer the assets, and distribute equity to the founders, employees, and investors, subject to the regulator's approval and the courts' scrutiny. That is precisely the transaction OpenAI has been attempting: a multi-step restructuring in which the nonprofit retains a stake in a new public-benefit corporation, capital is raised at a for-profit valuation, and the original mission is preserved in the corporate charter.

This is the legal terrain where Musk's $97.4 billion term sheet becomes a weapon. The moment the board opens the door to a sale — by entertaining a bid, by engaging with the bidder's bankers, by acknowledging the offer in a public filing — Delaware Chancery Court can be asked whether the directors have crossed from mission-driven stewardship into Revlon territory. The reverse is also true: if the board rejects the bid and proceeds with a for-profit conversion at a lower implied value, plaintiffs can argue the directors breached their duty to the nonprofit's constituents by leaving tens of billions of dollars on the table.

The Revlon problem in a nonprofit conversion is therefore a two-edged sword. Apply it, and the board must run a process designed to extract the highest price for the assets it controls. Refuse to apply it, and the board must explain to a Delaware judge why the nonprofit's mission justifies a sale price below market. Either path produces discovery, depositions, and a chancery-court record that can take years to compile. That is the chess move. Musk does not have to win the bid. He has to keep the bid alive long enough to make the conversion legally expensive.

The 409A Problem: How a Term Sheet Wrecks a Valuation

Here is the part the trade press has not fully digested. A 409A valuation is an independent, third-party appraisal of a private company's common stock, required by the IRS whenever a company issues options to employees or grants equity to founders. For OpenAI, the 409A is the foundation on which the for-profit conversion's price-per-share is built. If the 409A is too low, employees pay less in option-exercise taxes, but the company risks IRS challenge and employee lawsuits. If the 409A is too high, employees pay more tax and the company is treated as if its common stock has independent market value — which is the result everyone wants.

A credible, well-priced unsolicited bid destroys the 409A in two ways. First, the 409A appraiser can no longer credibly argue that the common stock is worth a fraction of the bid price; the bid becomes a comparable transaction. Second, the 409A is supposed to reflect fair market value on a stand-alone, going-concern basis — but a Revlon trigger re-orients the analysis toward liquidation-style "what would the highest bidder pay." A board that has just received a $97.4 billion term sheet cannot simultaneously represent to the IRS and to its employees that the company is worth a fraction of that figure. The conversion's share price, the employees' option-exercise cost, the secondary tender's implied valuation, and the nonprofit's retained stake in the public-benefit corporation all rest on a single appraisal that now has an elephant in the room.

In practice, this is what Musk's lawyers are buying for him with a $97.4 billion letter: a reset of every financial number inside the transaction, plus a Delaware docket number.

Counter-Reads and Counter-Moves

There is a plausible alternate read. The bid may be exactly what it appears: a serious attempt to acquire a competitor, financed by the rapidly appreciating equity in Tesla, SpaceX, and xAI. The legal chess interpretation assumes Musk's lawyers are more strategic than his dealmakers, and that the bid is intended to be rejected. The other read assumes the bid is intended to be accepted, on terms Musk can live with, after the board has been forced through a Revlon process that legitimises the price.

There is also a more cynical read. Sam Altman's framing — that Musk is "probably just trying to slow us down" — is the framing of a CEO who wants the for-profit conversion to close on the timeline his investors and employees are expecting, not on a Delaware chancery calendar. The most expensive outcome for OpenAI is not losing the bid. It is winning the legal fight and losing the conversion window. If the for-profit restructure slips into 2027 or 2028, the company's competitive position against Anthropic, Google DeepMind, and xAI itself shifts materially. Every month of delay is a month of cap-table drift, employee-option expiry, and investor patience. Musk's bid, on this read, is not a poison pill aimed at the board. It is a delay tactic aimed at the schedule.

The board's most likely counter-move is procedural: refer the bid to a special committee of independent directors, retain outside counsel, and decline to engage substantively while publicly reserving all rights. That is the standard Revlon-defence playbook, and it is what Microsoft did in 2022 when faced with an activist challenge to its Activision Blizzard acquisition. It is also what the OpenAI board did in 2023 when it fired Altman and then re-hired him five days later — a sequence that produced its own open governance wound. A board that has survived one open governance wound in 24 months is unlikely to be eager to volunteer for a second.

Stakes and Forward View

Three things to watch. First, the composition of the special committee and whether any of its members were on the board during the 2023 Altman dismissal, because that history will be Exhibit A in any plaintiffs' complaint. Second, the timing of OpenAI's next 409A refresh, because a bid that lives into Q3 2026 will force the appraiser to discount it heavily or to abandon the appraisal entirely. Third, the next round of OpenAI's tender-offer documents, which will either price as if the bid does not exist or price as if it does — and the difference between those two numbers is the size of the legal exposure the board is willing to accept.

The deeper question this bid raises is whether the for-profit conversion model is structurally compatible with a nonprofit mission. The board's lawyers will argue yes: the public-benefit corporation structure, the nonprofit's retained equity stake, and the mission-lock provisions in the corporate charter are sufficient to preserve the original purpose. Musk's lawyers will argue no: once equity holders exist, Revlon applies, and a mission is just a constraint on a price. That argument will not be resolved in a press release. It will be resolved in a Delaware courtroom, with discovery, expert testimony, and a chancellor who has seen this movie before.

Altman is right that the mission is not for sale. He is also right that Musk is not trying to buy it. Musk is trying to price it — in a forum where a price is the only thing that matters. That is what makes the $97.4 billion piece of paper a chess move rather than an offer, and that is why every board member, every employee holding options, and every investor holding a tender offer should be paying close attention to the next sixty days of Delaware corporate law. The conversion is not the story. The conversion's price tag is the story. And Musk just rewrote it.

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

• https://www.youtube.com/watch?v=imd1l4cPHv0